1
|
Machado S, Ewaldo Lindorfer Neto E, de Carvalho Dornelas B, de Martino Luppi A, Henrique de Oliveira E, Cesar Marinho Dias P, Dos Reis MQ, Dos Santos DF. Intramedullary Neurocysticercosis: A Case Report. Neurology 2023; 101:1023-1024. [PMID: 37813586 PMCID: PMC10727212 DOI: 10.1212/wnl.0000000000207911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 08/18/2023] [Indexed: 10/14/2023] Open
Affiliation(s)
- Stefano Machado
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG.
| | - Egon Ewaldo Lindorfer Neto
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Bruno de Carvalho Dornelas
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Andrea de Martino Luppi
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Elder Henrique de Oliveira
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Paulo Cesar Marinho Dias
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Maykell Queiroz Dos Reis
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| | - Diogo Fernandes Dos Santos
- From the HC-UFU (Neurology) (S.M.), HC-UFU (Neurosurgery) (E.E.L.N.), Pathology Departament (UFU/EBSERH) (B.C.D.), Radiology Division (A.M.L., E.H.O.), Clinics' Hospital, Federal University of Uberlândia (UFU/EBSERH), Neurosurgeon at Hospital de Clínicas de Uberlandia (UFU/EBSERH) (P.C.M.D.); Hospital de Clínicas de Uberlandia (UFU) (M.Q.R.); and Clinics' Hospital (D.F.S.), School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG
| |
Collapse
|
2
|
Laberiano-Fernández C, Luján JM, de Carvalho Dornelas B, Benites MF, Quispe PG, Vásquez VA, Espinoza AG, Guerra EG, Álvarez GGA, Astigueta-Pérez J, de Dávila MTG, Zambrano SC, Rojas TV, Mariños A, González ES, Lazcano R, Lastra RR, Alvarado-Cabrero I, Miller HG, Bardales RH, Abad-Licham M. Highlights from the 7th Oncological Pathology Conference 'Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American experience', 15, 22 and 23 July 2022, Trujillo, Peru. Ecancermedicalscience 2022; 16:1462. [PMID: 36819804 PMCID: PMC9934878 DOI: 10.3332/ecancer.2022.1462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Indexed: 11/06/2022] Open
Abstract
The seventh session of the Oncological Pathology Conference (JoPaO) entitled 'Pathological Anatomy in the context of the National Cancer Law: An overview of the Latin American experience', was held virtually on July 15, 22 and 23. Peru was the headquarters for this event, where 17 national and international professors of high academic standing participated. They interacted in a multidisciplinary context through talks with national panellists and the general public. The recent promulgation of the 'National Cancer Law' fosters the development of discussion forums to analyse the national realities and uphold continuous learning about experiences in other Latin American countries with successful cancer programmes, in which pathology holds a principal role. The topics addressed during this JoPaO included the exchange of Latin American cancer management experiences, an emphasis on investments in and the development of strategic plans to improve care, the use of new technologies, laboratory quality control, and the need to advance scientific research.
Collapse
Affiliation(s)
| | - Joan Moreno Luján
- Peruvian Society of Medical Oncology, Lima 15037, Peru,https://orcid.org/0000-0003-2621-7198
| | - Bruno de Carvalho Dornelas
- Clinical Hospital of the Federal University of Uberlandia, Uberlândia, MG, 38405-320,,https://orcid.org/0000-0003-1404-8876
| | - Magali Franco Benites
- Ramiro Prialé Prialé National Hospital, Huancayo 12006, Peru,https://orcid.org/0000-0002-4872-1646
| | - Patricia Gutiérrez Quispe
- Carlos Alberto Seguín Escobedo National Hospital, EsSalud, Arequipa 04001, Peru,https://orcid.org/0000-0002-1491-1556
| | - Valeria Aguilar Vásquez
- Northern Regional Institute of Neoplastic Diseases, Trujillo 13008, Peru,https://orcid.org/0000-0001-6889-0175
| | - Andric Guerrero Espinoza
- Northern Regional Institute of Neoplastic Diseases, Trujillo 13008, Peru,https://orcid.org/0000-0002-2619-1920
| | - Elsa Guerra Guerra
- Alberto Sabogal Sologuren National Hospital, Callao 07011, Peru,https://orcid.org/0000-0002-6320-1278
| | | | - Juan Astigueta-Pérez
- Antenor Orrego Private University School of Medicine, Trujillo 13008, Peru,https://orcid.org/0000-0001-5984-3270
| | - Maria Teresa Garcia de Dávila
- Garrahan and British Paediatric Hospital of Buenos Aires, Buenos Aires C1245 CABA, Argentina,https://orcid.org/0000-0002-3561-5035
| | - Sandro Casavilca Zambrano
- National Institute of Neoplastic Diseases, Lima, Surquillo 15038, Peru,https://orcid.org/0000-0001-8406-739X
| | - Tatiana Vidaurre Rojas
- National Institute of Neoplastic Diseases, Lima, Surquillo 15038, Peru,https://orcid.org/0000-0003-1995-4560
| | - Alejandro Mariños
- MD Anderson Cancer Center, Houston, TX 77030, United States,https://orcid.org/0000-0001-8179-5789
| | - Emmanuel S González
- Dr. Enrique Baltodano Briceño Hospital (HEBB), CCSS, Liberia 50101, Costa Rica,https://orcid.org/0000-0001-6204-3231
| | - Rossana Lazcano
- MD Anderson Cancer Center, Houston, TX 77030, United States,https://orcid.org/0000-0001-9890-2325
| | - Ricardo R Lastra
- The University of Chicago Medical Center, Chicago, IL 60637, United States,https://orcid.org/0000-0003-0691-5685
| | - Isabel Alvarado-Cabrero
- Star Medica Central Hospital, Mexico,Mexican Oncology Hospital, Mexico City 14080, Mexico,https://orcid.org/0000-0003-4000-9280
| | - Henry Guerra Miller
- National Institute of Neoplastic Diseases, Lima, Surquillo 15038, Peru,https://orcid.org/0000-0002-4894-5631
| | - Ricardo H Bardales
- Outpatient Pathology Associates/Precision Pathology, Sacramento, CA 95826, United States,https://orcid.org/0000-0003-1238-8535
| | - Milagros Abad-Licham
- Northern Regional Institute of Neoplastic Diseases, Trujillo 13008, Peru,Antenor Orrego Private University School of Medicine, Trujillo 13008, Peru,Centre of Excellence in Pathological Oncology, Trujillo 13011, Perú,https://orcid.org/0000-0002-3530-6937
| |
Collapse
|
3
|
Santana MADO, da Costa WVT, Celestino IC, dos Santos DF, Dornelas BDC, Pavelka MM, Luppi ADM, Goulart IMB. Fever of Unknown Origin, Wasting Syndrome and Bone Marrow Involvement: A Leprosy Case Report. Front Immunol 2022; 13:916319. [PMID: 35874693 PMCID: PMC9300819 DOI: 10.3389/fimmu.2022.916319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2022] [Accepted: 06/03/2022] [Indexed: 12/04/2022] Open
Abstract
Mycobacterium leprae, the etiologic agent of leprosy, is an acid-fast-staining and slow-growing bacilli that infect macrophages and Schwann cells individually or through forming globi. The clinical presentation of leprosy is broad and depends on the host immune response. We report a case of a 42-year-old Brazilian man presenting with fever of unknown origin (FUO), anemia, wasting syndrome, and neuropathy. The diagnosis of lepromatous leprosy was made after an extensive investigation revealed the presence of M. leprae in the bone marrow. Bone marrow involvement in leprosy is rare and some authors believe the presence of M. leprae in the bone marrow can act as a reservoir of the disease facilitating future relapses. It is important to investigate bone marrow involvement in leprosy, especially when the patient presents with cytopenias and positive epidemiologic history.
Collapse
Affiliation(s)
- Marcela Araujo de Oliveira Santana
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics’ Hospital, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
- *Correspondence: Marcela Araujo de Oliveira Santana,
| | | | - Isadora Costa Celestino
- Post-Graduation Program in Health Science, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
| | - Diogo Fernandes dos Santos
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics’ Hospital, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
- Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
| | - Bruno de Carvalho Dornelas
- Post-Graduation Program in Health Science, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
- Pathology Department, Clinical Hospital, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
| | | | - Andrea De Martino Luppi
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics’ Hospital, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
- Post-Graduation Program in Health Science, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
| | - Isabela Maria Bernardes Goulart
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics’ Hospital, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
- Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Brazil
| |
Collapse
|
4
|
Goulart IMB, Santana MADO, Costa WVTD, Pavelka MM, Dornelas BDC. Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy. IDCases 2022; 27:e01386. [PMID: 35036324 PMCID: PMC8749206 DOI: 10.1016/j.idcr.2022.e01386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Accepted: 01/05/2022] [Indexed: 11/16/2022] Open
Abstract
Type 2 leprosy reaction, or erythema nodosum leprosum (ENL), involves a complex interaction between the host's immune system and Mycobacterium leprae. It may occur before, during, or after treatment and have a variable clinical presentation involving different body systems, such as skin, osteoarticular, kidneys, and others. Thus, the differential diagnosis, depending on its clinical presentation, can be broad and challenging. The authors report a case of a severe monoarthritis during a type 2 reaction after the multidrug therapy (MDT) was discharged and the investigation of the differential diagnoses.
Collapse
Affiliation(s)
- Isabela Maria Bernardes Goulart
- School of Medicine, Federal University of Uberlândia (UFU), 1720, Pará avenue, Uberlândia, MG, Brazil.,Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), 94, Capricórnio Street, Uberlândia, MG, Brazil.,National Reference Center for Sanitary Dermatology and Leprosy, School of Medicine, Federal University of Uberlândia (UFU), 94, Capricórnio Street, Uberlândia, MG, Brazil
| | - Marcela Araujo de Oliveira Santana
- National Reference Center for Sanitary Dermatology and Leprosy, School of Medicine, Federal University of Uberlândia (UFU), 94, Capricórnio Street, Uberlândia, MG, Brazil
| | | | - Matthew Martin Pavelka
- Indiana University School of Medicine, 620 N. Chestnut Street Holmstedt Hall 135, Terre Haute, IN 47809, USA
| | | |
Collapse
|
5
|
Mendes do Nascimento AC, Dos Santos DF, Antunes DE, Gonçalves MA, Santana MADO, Dornelas BDC, Goulart Filho LR, Goulart IMB. Leprosy Relapse: a Retrospective Study on Epidemiological, Clinical and Therapeutics Aspects at a Brazilian Referral Center. Int J Infect Dis 2022; 118:44-51. [PMID: 35017109 DOI: 10.1016/j.ijid.2022.01.009] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2021] [Revised: 12/14/2021] [Accepted: 01/05/2022] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVES We aim to characterize the profile of patients diagnosed with leprosy relapse and understand the influence of different multidrug therapy (MDT) treatments and initial disease presentation. METHODS This retrospective study included patients diagnosed with leprosy relapse at a referral center in Brazil from 2013-2018. We analyzed their clinical-epidemiological characteristics, laboratory, and bacilloscopic tests. Survival analysis was used to determine the time elapsed until relapse, according to the previous treatment and the disease clinical forms. RESULTS 126 cases of relapse were analyzed, which comprised 11.89% (126/1059) of the cases. The median time elapsed until relapse was 10 years, and most patients had previously undergone 12 doses of MDT (40.48%; 51/126). Undergoing 24 doses of MDT was associated with a better prognosis regarding relapse over time compared to six or 12 doses of MDT therapy. Most of the cases of relapse were classified as multibacillary (96.03%; 121/126). CONCLUSION The incidence of relapse was greater than observed in other studies. The high percentage of multibacillary patients who had negative bacillary indices demonstrated that the bacillary index cannot be considered to be an essential criterion for relapse, especially with regard to making an early diagnosis.
Collapse
Affiliation(s)
| | - Diogo Fernandes Dos Santos
- Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Douglas Eulálio Antunes
- Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Maria Aparecida Gonçalves
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Marcela Araujo de Oliveira Santana
- National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Bruno de Carvalho Dornelas
- Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Luiz Ricardo Goulart Filho
- Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; Institute of Genetics and Biochemistry, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Isabela Maria Bernardes Goulart
- Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil; National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil.
| |
Collapse
|
6
|
Mota STS, Vecchi L, Alves DA, Cordeiro AO, Guimarães GS, Campos-Fernández E, Maia YCP, Dornelas BDC, Bezerra SM, de Andrade VP, Goulart LR, Araújo TG. Annexin A1 promotes the nuclear localization of the epidermal growth factor receptor in castration-resistant prostate cancer. Int J Biochem Cell Biol 2020; 127:105838. [PMID: 32858191 DOI: 10.1016/j.biocel.2020.105838] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 07/30/2020] [Accepted: 08/20/2020] [Indexed: 12/24/2022]
Abstract
Epidermal growth factor receptor is a cancer driver whose nuclear localization has been associated with the progression of prostate cancer to the castration-resistant phenotype. Previous reports indicated a functional interaction between this receptor and the protein Annexin A1, which has also been associated with aggressive tumors. The molecular pathogenesis of castration-resistant prostate cancer remains largely unresolved, and herein we have demonstrated the correlation between the expression levels and localization of the epidermal growth factor receptor and Annexin A1 in prostate cancer samples and cell lines. Interestingly, a higher expression of both proteins was detected in castration-resistant prostate cancer cell lines and the strongest correlation was seen at the nuclear level. We verified that Annexin A1 interacts with the epidermal growth factor receptor, and by using prostate cancer cell lines knocked down for Annexin A1, we succeeded in demonstrating that Annexin A1 promotes the nuclear localization of epidermal growth factor receptor. Finally, we showed that Annexin A1 activates an autocrine signaling in castration-resistant prostate cells through the formyl peptide receptor 1. The inhibition of such signaling by Cyclosporin H inhibits the nuclear localization of epidermal growth factor receptor and its downstream signaling. The present work sheds light on the functional interaction between nuclear epidermal growth factor receptor and nuclear Annexin A1 in castration-resistant prostate cancer. Therefore, strategies to inhibit the nuclear localization of epidermal growth factor receptor through the suppression of the Annexin A1 autocrine loop could represent an important intervention strategy for castration-resistant prostate cancer.
Collapse
Affiliation(s)
- Sara Teixeira Soares Mota
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | - Lara Vecchi
- Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | - Douglas Alexsander Alves
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | - Antonielle Oliveira Cordeiro
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | - Gabriela Silva Guimarães
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | - Esther Campos-Fernández
- Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | | | - Bruno de Carvalho Dornelas
- Pathology Division, Internal Medicine, University Hospital, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| | | | | | - Luiz Ricardo Goulart
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; University of California, Davis, Dept. of Medical Microbiology and Immunology, Davis, CA, 95616, USA.
| | - Thaise Gonçalves Araújo
- Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas, MG, 387400-128, Brazil; Laboratory of Nanobiotechnology, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, MG, 38400-902, Brazil.
| |
Collapse
|